2004Chinese New Drugs JournalRequires access

Comparison of in vitro antibacterial activities for different ratio of amoxicillin/sulbactam

Xiuzhen Zhang

Open publisher page 0 citations

Abstract

Objective:To evaluate the antibacterial activities in vitro of amoxicillin/sulbactam (2:1 and 4:1). Methods:Minimal inhibitory concentrations (MIC) were determined by agar double dilution. Of 620 strains of clinical organisms, 502 cultures of organisms were found to be able to produce β-lactamases (80.97%). Results:Two combinations of amoxicillin/sulbactam (2:1 and 4:1) all showed resistant antibacterial activities with fluctuated MIC range,MIC50 and MIC90 in 1-2 times on the following organisms: Escherichia coli of ESBL, Klebsiella pneumoniae of ESBL, Enterobacter spp producing AmpC enzyme and non-fermentation gram negative rod ( Pseudomonas aeruginosa , Acineto-bacter spp, Stenophotomonas maltophilus). Two combinations of amoxicillin/sulbactam (2:1 and 4:1) also gave an equivalent titer in the MIC range,MIC50 and MIC90 on common pathogenic bacteria that cause community infection,i.e. ,Haemophilus Influenza producing β-lactamases,Moraxella catarrh , MSSA and MSSCoN, Streptococcus pneumoniae, β-haemolysis Streptococcus and Enterococcus fae-calis. Conclusion: Amoxicillin/sulbactam (4:1) was found to have the same antibacterial activity as amoxicillin/sulbactam (2:1).

About this research paper

What this paper is about

Objective:To evaluate the antibacterial activities in vitro of amoxicillin/sulbactam (2:1 and 4:1). Methods:Minimal inhibitory concentrations (MIC) were determined by agar double dilution. Of 620 strains of clinical organisms, 502 cultures of organisms were found to be able to produce β-lactamases (80.97%). Results:Two combinations of amoxicillin/sulbactam (2:1 and 4:1) all showed resistant antibacterial activities with fluctuated MIC range,MIC50 and MIC90 in 1-2 times on the following organisms: Escherichia coli of ESBL, Klebsiella pneumoniae of ESBL, Enterobacter spp producing AmpC enzyme and non-fermentation gram negative rod ( Pseudomonas aeruginosa , Acineto-bacter spp, Stenophotomonas maltophilus). Two combinations of amoxicillin/sulbactam (2:1 and 4:1) also gave an equivalent titer in the MIC range,MIC50 and MIC90 on common pathogenic bacteria that cause community infection,i.e. ,Haemophilus Influenza producing β-lactamases,Moraxella catarrh , MSSA and MSSCoN, Streptococcus pneumoniae, β-haemolysis Streptococcus and Enterococcus fae-calis. Conclusion: Amoxicillin/sulbactam (4:1) was found to have the same antibacterial activity as amoxicillin/sulbactam (2:1).

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To evaluate the antibacterial activities in vitro of amoxicillin/sulbactam (2:1 and 4:1). Methods:Minimal inhibitory concentrations (MIC) were determined by agar double dilution. Of 620 strains of clinical organisms, 502 cultures of organisms were found to be able to produce β-lactamases (80.97%). Results:Two combinations of amoxicillin/sulbactam (2:1 and 4:1) all showed resistant antibacterial activities with fluctuated MIC range,MIC50 and MIC90 in 1-2 times on the following organisms: Escherichia coli of ESBL, Klebsiella pneumoniae of ESBL, Enterobacter spp producing AmpC enzyme and non-fermentation gram negative rod ( Pseudomonas aeruginosa , Acineto-bacter spp, Stenophotomonas maltophilus). Two combinations of amoxicillin/sulbactam (2:1 and 4:1) also gave an equivalent titer in the MIC range,MIC50 and MIC90 on common pathogenic bacteria that cause community infection,i.e. ,Haemophilus Influenza producing β-lactamases,Moraxella catarrh , MSSA and MSSCoN, Streptococcus pneumoniae, β-haemolysis Streptococcus and Enterococcus fae-calis. Conclusion: Amoxicillin/sulbactam (4:1) was found to have the same antibacterial activity as amoxicillin/sulbactam (2:1).

Key concepts: Microbiology, Amoxicillin, Sulbactam, Streptococcus pneumoniae, Haemophilus, Agar dilution, Klebsiella pneumoniae, Biology

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparison of in vitro antibacterial activities for different ratio of amoxicillin/sulbactam — Research Paper | ScholarLens